FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Final Year of CMC Development Pilot Opens Oct. 1

FDA begins next month accepting requests from drug and biologics sponsors seeking to participate in the fifth and final year of its Chemistry, Manufac...

latest-news-card-1
Human Drugs

Senate Drug Manufacturing Transparency Bill Watered Down

A bipartisan Senate bill intended to give patients and health care providers more information about where prescription drugs are manufactured loses tw...

FDA General

Kennedy Vaccine Remarks Raise Stakes for Overton Confirmation Hearing

HHS secretary Robert F. Kennedy Jr.'s vaccine skepticism remarks this week likely complicate Heidi Overtons upcoming confirmation hearing to lead FDA....

latest-news-card-1
Human Drugs

FDA Approves Lilly Combo for Metastatic Breast Cancer

FDA grants Eli Lilly full approval for the combination use of Inluriyo (imlunestrant) with Verzenio (abemaciclib) in certain adults with estrogen rece...

latest-news-card-1
Human Drugs

20 State AGs Warn About Chinese API Suppliers for GLP-1s

A coalition of 20 state attorneys general urge the Trump administration to tighten or suspend an FDA import program, alleging that Chinese suppliers a...

latest-news-card-1
Human Drugs

Brookfield Medical Cited on Repeated Potency Failures

FDA cites Connecticut outsourcing facility Brookfield Medical/Surgical Supplies for inadequate investigations involving 13 out-of-specification potenc...

latest-news-card-1

Many FDA-Ordered Postmarket Studies Not Done

A KFF Health News report documents hundreds of FDA-mandated postmarket studies whose reports are listed as delayed.

latest-news-card-1
Biologics

Interchangeable Product Development Strategy Outlined

FDA issues a strategy document summarizing discussions at a 2025 workshop on developing interchangeable biosimilar products.

latest-news-card-1
Biologics

Ultragenyx Gains Approval for Resubmitted Gene Therapy

FDA approves Ultragenyx Pharmaceuticals Fayuvi (rebisufligene etisparvovec-hopf), the first treatment for pediatric patients with Sanfilippo syndrome ...

latest-news-card-1
FDA General

FDA Commissioner Nominee Overton Gets 9/24 Confirmation Hearing

The Senate HELP Committee sets a 9/24 confirmation hearing on the nomination of Heidi Overton to be the next FDA commissioner.